Chongqing Genrix Biopharmaceutical Co., Ltd. Class ASSE: 688443

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

May 20, 2025 · Issued by Chongqing Genrix Biopharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening Performance Briefing for 2024 and Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment